The first biotech IPO of the new decade has landed — and of course it's another cancer drug developer
The first biotech IPO of 2020 is here, and it’s for a company founded by two marquee names in oncology.
Cambridge-based Black Diamond Therapeutics filed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
